Biophytis Announces New Scientific Advisory Board for its Phase 2 OBA Clinical Study in Obesity stlouisstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from stlouisstar.com Daily Mail and Mail on Sunday newspapers.
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in the development of therapeutics for age-related diseases, today announces the formation of a new.
Neural Therapeutics Inc : Neural Therapeutics Announces Board of Directors Appointments and IP Development Agreement with Validity Labs finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Lyon, France – 12 April 2023 – 6pm CEST – Theranexus, a biopharmaceutical company innovating in the treatment of rare neurological diseases and pioneer in the development of drug. | April 12, 2023